Evidence map›Paper›PMID 23454758›Full record

ReviewThe Journal of clinical investigation2013

Causes, consequences, and reversal of immune system aging.

Encarnacion Montecino-Rodriguez, Beata Berent-Maoz, Kenneth Dorshkind

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 417 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
417citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

417 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Acute priming using elevated fluid viscosity recovers 'bioRxiv : the preprint server for biology · 2026
    Article
  19. Review
  20. Article

357 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Encarnacion Montecino-RodriguezDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Beata Berent-Maoz
Kenneth Dorshkind

Funding

Effects of p16Ink4a and Arf on T Lineage AgingR01AG034875 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DORSHKIND, KENNETH ALLAN · 2009 to 2013
$1.8M
NIA NIH HHS AG034875NIA NIH HHS R01 AG034875
6 · The paper itself

Abstract

The effects of aging on the immune system are manifest at multiple levels that include reduced production of B and T cells in bone marrow and thymus and diminished function of mature lymphocytes in secondary lymphoid tissues. As a result, elderly individuals do not respond to immune challenge as robustly as the young. An important goal of aging research is to define the cellular changes that occur in the immune system and the molecular events that underlie them. Considerable progress has been made in this regard, and this information has provided the rationale for clinical trials to rejuvenate the aging immune system.

Indexed as

AgingAnimalsHematopoietic Stem CellsHumansImmune SystemImmunologic FactorsLymphoid Progenitor CellsImmunologic Factors

Identifiers

PMID23454758
PMCPMC3582124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.